Bank Of America Corp Theseus Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.12 - $4.18 $51,728 - $101,992	24,400 Added 609.7%	28,402 $115,000
Q2 2023 Aug 14, 2023	SELL	$7.28 - $11.82 $1.28 Million - $2.07 Million	-175,200 Reduced 97.77%	4,002 $37,000
Q1 2023 May 12, 2023	BUY	$5.21 - $14.05 $857,472 - $2.31 Million	164,582 Added 1125.73%	179,202 $1.59 Million
Q4 2022 Feb 10, 2023	BUY	$4.69 - $8.36 $40,920 - $72,941	8,725 Added 148.01%	14,620 $72,000
Q3 2022 Nov 14, 2022	SELL	$5.7 - $8.68 $2,844 - $4,331	-499 Reduced 7.8%	5,895 $35,000
Q2 2022 Aug 12, 2022	BUY	$5.04 - $14.05 $6,652 - $18,546	1,320 Added 26.01%	6,394 $35,000
Q1 2022 May 16, 2022	SELL	$8.75 - $14.51 $24,780 - $41,092	-2,832 Reduced 35.82%	5,074 $59,000
Q4 2021 Feb 08, 2022	BUY	$8.98 - $20.09 $70,995 - $158,831	7,906 New	7,906 $100,000

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.